• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

阿斯利康新冠疫苗：缺血性中风和大脑静脉矢状窦血栓形成的一个可能风险因素：病例系列

AstraZeneca COVID-19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series.

作者信息

Siddig Amira, Abbasher Hussien Mohamed Ahmed Khabab, Hassan Haroun Mazin S, M Abdallah Abdallah, Malekaldar Mohamed, Abbasher Al Hussien, Abbasher Mohammed, Abbasher Abubaker Alsedig, Hussien Abbasher

机构信息

Faculty of Medicine AlNeelain University Khartoum Sudan.

Faculty of Medicine University of Khartoum Khartoum Sudan.

出版信息

Clin Case Rep. 2022 Jul 11;10(7):e6017. doi: 10.1002/ccr3.6017. eCollection 2022 Jul.

DOI:10.1002/ccr3.6017
PMID:35846901
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9272208/
Abstract

One of the most prevalent neurological impairments is cerebrovascular accident (CVA). Ischemic stroke and CVST have been linked to the AstraZeneca COVID-19 vaccine. Three Sudanese patients developed these diseases after receiving the AstraZeneca COVID-19 vaccine, indicating a relationship between the AstraZeneca COVID-19 vaccine and these conditions.

摘要

最常见的神经功能障碍之一是脑血管意外（CVA）。缺血性中风和脑静脉窦血栓形成（CVST）与阿斯利康新冠疫苗有关。三名苏丹患者在接种阿斯利康新冠疫苗后患上了这些疾病，这表明阿斯利康新冠疫苗与这些病症之间存在关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ae/9272208/ba0eb3812af7/CCR3-10-e6017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ae/9272208/ca9ac6767989/CCR3-10-e6017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ae/9272208/ba0eb3812af7/CCR3-10-e6017-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ae/9272208/ca9ac6767989/CCR3-10-e6017-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/46ae/9272208/ba0eb3812af7/CCR3-10-e6017-g001.jpg

相似文献

1
AstraZeneca COVID-19 vaccine: A possible risk factor for ischemic stroke and cerebral venous sagittal sinus thrombosis: A case series.阿斯利康新冠疫苗：缺血性中风和大脑静脉矢状窦血栓形成的一个可能风险因素：病例系列
Clin Case Rep. 2022 Jul 11;10(7):e6017. doi: 10.1002/ccr3.6017. eCollection 2022 Jul.
2
Vaccine-induced immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis post COVID-19 vaccination; a systematic review.疫苗接种后 COVID-19 疫苗诱导的免疫性血栓性血小板减少症和脑静脉窦血栓形成：系统评价。
J Neurol Sci. 2021 Sep 15;428:117607. doi: 10.1016/j.jns.2021.117607. Epub 2021 Aug 3.
3
Thrombocytopenia and Intracranial Venous Sinus Thrombosis after "COVID-19 Vaccine AstraZeneca" Exposure.接种阿斯利康“新冠疫苗”后出现血小板减少症和颅内静脉窦血栓形成
J Clin Med. 2021 Apr 9;10(8):1599. doi: 10.3390/jcm10081599.
4
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.美国 2021 年 3 月 2 日至 4 月 21 日 Ad26.COV2.S 疫苗接种后出现脑静脉窦血栓形成伴血小板减少的病例报告。
JAMA. 2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517.
5
Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.接种 SARS-CoV-2 疫苗后的脑静脉窦血栓形成：向欧洲药品管理局报告的病例分析。
Eur J Neurol. 2021 Nov;28(11):3656-3662. doi: 10.1111/ene.15029. Epub 2021 Aug 4.
6
Cerebral venous sinus thrombosis after adenovirus-vectored COVID-19 vaccination: review of the neurological-neuroradiological procedure.腺病毒载体 COVID-19 疫苗接种后发生脑静脉窦血栓形成：神经-神经放射学处理综述。
Neuroradiology. 2022 May;64(5):865-874. doi: 10.1007/s00234-022-02914-z. Epub 2022 Feb 19.
7
Extensive Cerebral Venous Sinus Thrombosis (CVST) After the First Dose of Pfizer-BioNTech BNT162b2 mRNA COVID-19 Vaccine without Thrombotic Thrombocytopenia Syndrome (TTS) in a Healthy Woman.健康女性在接种第一剂辉瑞-生物科技 BNT162b2 mRNA COVID-19 疫苗后发生广泛脑静脉窦血栓形成（CVST），但无血栓性血小板减少综合征（TTS）。
Am J Case Rep. 2022 Feb 9;23:e934744. doi: 10.12659/AJCR.934744.
8
Clinical profile and risk factors of cerebral venous sinus thrombosis (CVST) in Sudan: A multicenter cross-sectional study.苏丹脑静脉窦血栓形成（CVST）的临床特征及危险因素：一项多中心横断面研究。
Ann Med Surg (Lond). 2022 Nov 17;84:104891. doi: 10.1016/j.amsu.2022.104891. eCollection 2022 Dec.
9
ChAdOx1 nCoV-19 AstraZeneca COVID-19 vaccine.ChAdOx1 nCoV-19阿斯利康新冠疫苗。
JRSM Cardiovasc Dis. 2023 Apr 11;12:20480040231169464. doi: 10.1177/20480040231169464. eCollection 2023 Jan-Dec.
10
[Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management].[新冠疫苗接种后发生脑静脉窦血栓形成：神经学及影像学处理]
Radiologe. 2021 Oct;61(10):923-932. doi: 10.1007/s00117-021-00887-3. Epub 2021 Jul 29.

引用本文的文献

1
Case Report of Serum Sickness-like Reaction following the First Dose of the Chimpanzee Adenovirus-Vectored AstraZeneca COVID-19 Vaccine, ChAdOx1.首例接种黑猩猩腺病毒载体阿斯利康新冠疫苗ChAdOx1后发生血清病样反应的病例报告
Vaccines (Basel). 2023 Feb 17;11(2):467. doi: 10.3390/vaccines11020467.
2
Cerebral venous sinus thrombosis following intracerebral hemorrhage after COVID-19 AstraZeneca vaccination: A case report.新冠疫苗阿斯利康接种后脑出血继发脑静脉窦血栓形成：一例报告
Clin Case Rep. 2022 Nov 15;10(11):e6505. doi: 10.1002/ccr3.6505. eCollection 2022 Nov.

本文引用的文献

1
Lessons from vaccine-induced immune thrombotic thrombocytopenia.疫苗诱导的免疫性血栓性血小板减少症的教训。
Nat Rev Immunol. 2021 Dec;21(12):753-755. doi: 10.1038/s41577-021-00642-8.
2
Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study.英国接种新冠疫苗后发生的脑静脉血栓形成：一项多中心队列研究。
Lancet. 2021 Sep 25;398(10306):1147-1156. doi: 10.1016/S0140-6736(21)01608-1. Epub 2021 Aug 6.
3
Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia.疫苗诱导免疫性血栓性血小板减少症的抗体表位。
Nature. 2021 Aug;596(7873):565-569. doi: 10.1038/s41586-021-03744-4. Epub 2021 Jul 7.
4
Neurosurgical Considerations Regarding Decompressive Craniectomy for Intracerebral Hemorrhage after SARS-CoV-2-Vaccination in Vaccine Induced Thrombotic Thrombocytopenia-VITT.关于疫苗诱导的血栓性血小板减少症（VITT）中 SARS-CoV-2 疫苗接种后脑出血减压性颅骨切除术的神经外科考量
J Clin Med. 2021 Jun 24;10(13):2777. doi: 10.3390/jcm10132777.
5
Ischaemic stroke as a presenting feature of ChAdOx1 nCoV-19 vaccine-induced immune thrombotic thrombocytopenia.缺血性中风作为ChAdOx1 nCoV-19疫苗诱导的免疫性血栓性血小板减少症的首发症状。
J Neurol Neurosurg Psychiatry. 2021 Nov;92(11):1247-1248. doi: 10.1136/jnnp-2021-326984. Epub 2021 May 25.
6
US Case Reports of Cerebral Venous Sinus Thrombosis With Thrombocytopenia After Ad26.COV2.S Vaccination, March 2 to April 21, 2021.美国 2021 年 3 月 2 日至 4 月 21 日 Ad26.COV2.S 疫苗接种后出现脑静脉窦血栓形成伴血小板减少的病例报告。
JAMA. 2021 Jun 22;325(24):2448-2456. doi: 10.1001/jama.2021.7517.
7
The emerging association between COVID-19 and acute stroke.新型冠状病毒肺炎与急性脑卒中的相关性。
Trends Neurosci. 2021 Jul;44(7):527-537. doi: 10.1016/j.tins.2021.03.005. Epub 2021 Apr 8.
8
Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination.接种 ChAdOx1 nCov-19 疫苗后发生血栓性血小板减少症。
N Engl J Med. 2021 Jun 3;384(22):2092-2101. doi: 10.1056/NEJMoa2104840. Epub 2021 Apr 9.
9
Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination.ChAdOx1新冠疫苗接种后的血栓形成和血小板减少症
N Engl J Med. 2021 Jun 3;384(22):2124-2130. doi: 10.1056/NEJMoa2104882. Epub 2021 Apr 9.
10
SARS-CoV-2 vaccines strategies: a comprehensive review of phase 3 candidates.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）疫苗策略：对3期候选疫苗的全面综述
NPJ Vaccines. 2021 Feb 22;6(1):28. doi: 10.1038/s41541-021-00292-w.